Actively Recruiting
Predictors of Failed Thrombolysis in Acute Myocardial Infarction
Led by Oslo University Hospital · Updated on 2023-03-23
200
Participants Needed
1
Research Sites
662 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this observational study is to assess why thrombolytic treatment with tissue-plasminogen activator (t-PA) fails in patients with acute ST-segment elevation myocardial infarction (STEMI). The study will include 200 STEMI patients at the time of arrival at Oslo University Hospital Ullevål after receiving prehospital thrombolysis. A blood sample will be taken immediately for the study of factors related to coagulation, fibrinolysis and inflammation. Levels of the biomarkers will be compared between patients with successful and failed thrombolysis.
CONDITIONS
Official Title
Predictors of Failed Thrombolysis in Acute Myocardial Infarction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- STEMI patients > 18 years given prehospital thrombolysis.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hospital
Oslo, Norway
Actively Recruiting
Research Team
R
Ragnhild Helseth, MD PhD
CONTACT
K
Kristine Kindberg, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here